0 Yorumlar
0 hisse senetleri
307 Views
0 önizleme
Sponsorluk
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Biotech Partnerships Accelerate FTD Drug DevelopmentThe frontotemporal disorders treatment market, addressing rare but impactful neurodegenerative diseases, is poised for steady growth. Valued at USD 343.8 million in 2022, it is projected to reach USD 451.4 million by 2028, up at a 4.6% CAGR (2022–28). Frontotemporal Disorders Treatment Market Request a sample copy of the research report:...0 Yorumlar 0 hisse senetleri 258 Views 0 önizleme
-
U.S. Advances RNAi Research with FDA Approvals and Biotech FundingThe global RNAi Technology Market was valued at USD 1.6 billion in 2022 and is projected to reach USD 3.6 billion by 2031, growing at a CAGR of 10.3% during the forecast period 2024–2031. RNA interference (RNAi) utilizes small nucleic acid fragments to silence genes post-transcriptionally, enabling the treatment of cancer and other complex disorders with high specificity. This technique...0 Yorumlar 0 hisse senetleri 301 Views 0 önizleme
-
U.S. Biotech Surge Fuels Exosome-Based Liquid Biopsy DevelopmentThe global exosomes market reached US$ 1.3 billion in 2023 and is projected to grow to US$ 2.7 billion by 2031, at a CAGR of 15.6% during the forecast period 2024–2031, driven by expanding applications in oncology, immunotherapy, and regenerative medicine. Exosomes small vesicles ranging from 30 to 200 nm—mediate critical intercellular signaling, including EGFR-related mechanisms...0 Yorumlar 0 hisse senetleri 162 Views 0 önizleme
-
Digital Monitoring Tools Improve Huntington’s Disease ManagementThe global Huntington’s disease (HD) market is forecast to reach USD 1.9 billion by 2031, up from USD 961 million in 2023, growing at a compound annual growth rate (CAGR) of 9.1% during the forecast period. Fueled by increasing clinical trials, breakthroughs in RNA interference, and growing awareness, the HD market is poised for significant transformation. Huntington’s disease is a...0 Yorumlar 0 hisse senetleri 134 Views 0 önizleme
-
Green Enzymes and Bioplastics Propel Industrial SegmentThe global Recombinant DNA (rDNA) Technology Market is on track to grow from an estimated USD 798 billion in 2023 to USD 1,395 billion by 2032, registering a steady compound annual growth rate (CAGR) of 6.4%. The market is being propelled by expanding applications in pharmaceuticals, agriculture, industrial biotechnology, and environmental sustainability. Market Snapshot 2023 Market Size:...0 Yorumlar 0 hisse senetleri 116 Views 0 önizleme
Sponsorluk